Puriman Group

Puriman Group is a South Korean biotechnology company specializing in the development of exosome-based therapeutics and advanced healthcare solutions. The company leverages its proprietary Exo-Puriman platform, which facilitates the high-purity isolation and purification of exosomes derived from stem cells. Puriman's research and development efforts are primarily focused on regenerative medicine and inflammatory conditions, with a pipeline targeting alopecia, atopic dermatitis, and osteoarthritis. In addition to its therapeutic programs, the company applies its exosome technology to the cosmeceutical market, offering products for skin rejuvenation and anti-aging. By ensuring standardized and safe exosome production, Puriman Group aims to establish itself as a leader in the global exosome therapy market.